Edwards Lifesciences Aktie
WKN: 936853 / ISIN: US28176E1082
23.07.2020 22:33:50
|
Edwards Lifesciences Corp. Q2 adjusted earnings Beat Estimates
(RTTNews) - Below are the earnings highlights for Edwards Lifesciences Corp. (EW):
-Earnings: -$121.9 million in Q2 vs. $242.3 million in the same period last year. -EPS: -$0.20 in Q2 vs. $0.38 in the same period last year. -Excluding items, Edwards Lifesciences Corp. reported adjusted earnings of $213.5 million or $0.34 per share for the period. -Analysts projected $0.17 per share -Revenue: $0.93 billion in Q2 vs. $1.09 billion in the same period last year.
-Guidance: Next quarter revenue guidance: $1.0 - $1.2 Bln Full year EPS guidance: $1.75 - $1.95 Full year revenue guidance: $4.0 - $4.5 Bln

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Edwards Lifesciences Corp.mehr Nachrichten
Analysen zu Edwards Lifesciences Corp.mehr Analysen
Aktien in diesem Artikel
Edwards Lifesciences Corp. | 66,06 | -0,63% |
|